Needed: Cash to pay for innovation
A $500 ticket to the Biotech conference Monday and Tuesday offered face time with heavy-hitting investors. After an 18-month, deep recession that dried up funding for drug research and development...
View ArticleGephardt visits Triangle on tour to spur medical innovation
Dick Gephardt is traveling across the country to reinvigorate medical innovation and on Wednesday the former Congressman, U.S. House majority leader and two-time Democratic presidential candidate...
View ArticleOn the future of personal genomics and the law…
Dan Vorhaus Dan Vorhaus is a lawyer with Robinson Bradshaw and Hinson in Charlotte, N.C. where a portion of his practice comprises the growing field of personal genomics law. Given the interest in...
View ArticleEngineering for Better Wastewater Treatment Results
Wayne Flournoy, president of Entex Technologies A few weeks ago, I reported on water quality expert Kenneth Reckhow’s concern that we will be unable to achieve water quality standards set by states in...
View ArticleNorth Carolina’s biotech industry gets wakeup call
Buyers looking for a kitchen appliance, computer or car can turn to a variety of product reviews and ratings, but there’s no version of Consumer Reports that helps physicians or patients with...
View ArticleBayer continues to shift biotech seed development focus to U.S.
Rendering of Bayer CropScience's new greenhouse. The 60,000-square-foot greenhouse that Bayer CropsScience is building in North Carolina’s Research Triangle Park represents a critical step in a...
View ArticleBiotech innovation: What isn’t funded
Innovation capital, money to turn some of today’s most innovative discoveries into tomorrow’s medical treatments, is getting so scarce in the U.S., politicians, economic developers and entrepreneurs in...
View ArticleHamner signs Chinese collaborator
Two years after the Hamner Institutes for Health Sciences set up a gateway to China, the Research Triangle Park research institute is adding a Chinese company to its collaborators. Ascletis will...
View ArticleRTP biotech companies travel to Bay Area to pitch to investors
Young biotech companies in North Carolina’s Research Triangle don’t have to read Ernst & Young’s 2011 industry report to know that early stage funding is down, that investors increasingly tranch...
View ArticleNC biotech industry eyes unique chance to shape the FDA
Gov. Beverly Perdue’s announcement that a California biotech will set up shop in North Carolina’s Research Triangle was a welcome but short-lived diversion Wednesday during the annual meeting of the...
View Article